Ascendis Pharma A/S
ASND164.150USD
+3.700+2.31%
收盘 04/25, 16:00（美东）报价延迟15分钟
9.95B总市值
亏损市盈率 TTM
关于 Ascendis Pharma A/S 公司
Ascendis Pharma A/S 是一家总部位于丹麦的制药产品生产公司。该公司生产的产品用于治疗生长激素缺乏症、内分泌学、中枢神经系统疾病、传染病和糖尿病。该公司通过其子公司在全球开展业务：Ascendis Pharma GmbH（德国）、Ascendis Pharma, Inc.（美国特拉华州）、Ascendis Pharma Endocrinology, Inc.（美国特拉华州）、Ascendis Pharma, Ophthalmology Division A/S（丹麦）、Ascendis Pharma, Endocrinology Division A/S（丹麦）、Ascendis Pharma Bone Diseases A/S（丹麦）、Ascendis Pharma Growth Disorders A/S（丹麦）和 Ascendis Pharma Oncology Division A/S（丹麦）。
公司简介
公司代码ASND
公司名称Ascendis Pharma A/S
上市日期Jan 28, 2015
成立日期2006
CEOMr. Jan Moller Mikkelsen
员工数量- -
证券类型Depository Receipt
年结日Jan 28
公司地址Tuborg Boulevard 12
城市HELLERUP
上市交易所NASDAQ Global Select Consolidated
国家Denmark
邮编2900
电话4570222244
网址https://ascendispharma.dk/
公司代码ASND
上市日期Jan 28, 2015
成立日期2006
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
Mr. Mads Bodenhoff
Mr. Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Senior Vice President, Head of Finance and Principal Accounting Officer
193.00
--
Mr. Donovan (Jay) Wu
Mr. Donovan (Jay) Wu
Executive Vice President, U.S. President
Executive Vice President, U.S. President
--
--
Dr. Aimee Shu,, M.D.
Dr. Aimee Shu,, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Mr. William Carl (Bill) Fairey, Jr.
Mr. William Carl (Bill) Fairey, Jr.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
收入明细
单位: EUR更新时间: 4月6日 周日
单位: EUR更新时间: 4月6日 周日
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务EUR
名称
营收
占比
Commercial sale of products
55.71M
96.33%
Rendering of services
1.27M
2.20%
License
851.00K
1.47%
Sale of clinical supply
0.00
0.00%
地区EUR
名称
营收
占比
North America
48.76M
84.31%
Europe
8.15M
14.09%
Asia
924.00K
1.60%
Rest of world
924.00K
1.60%
业务
地区
业务EUR
名称
营收
占比
Commercial sale of products
55.71M
96.33%
Rendering of services
1.27M
2.20%
License
851.00K
1.47%
Sale of clinical supply
0.00
0.00%
股东统计
更新时间: 4月26日 周六
更新时间: 4月26日 周六
持股股东
股东类型
持股股东
股东统计
占比
RA Capital Management, LP
16.66%
Westfield Capital Management Company, L.P.
9.11%
Avoro Capital Advisors LLC
8.41%
Artisan Partners Limited Partnership
7.33%
Janus Henderson Investors
7.22%
Other
51.27%
持股股东
股东统计
占比
RA Capital Management, LP
16.66%
Westfield Capital Management Company, L.P.
9.11%
Avoro Capital Advisors LLC
8.41%
Artisan Partners Limited Partnership
7.33%
Janus Henderson Investors
7.22%
Other
51.27%
股东类型
股东统计
占比
Investment Advisor/Hedge Fund
42.21%
Investment Advisor
39.31%
Hedge Fund
25.01%
Research Firm
2.54%
Individual Investor
0.78%
Family Office
0.44%
Family Office
0.44%
Family Office
0.44%
Venture Capital
0.38%
机构持股
更新时间: 1月20日 周一
更新时间: 1月20日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q1
473
67.43M
111.11%
-2.45M
2024Q4
488
67.37M
111.00%
-7.76M
2024Q3
475
65.25M
107.66%
-6.23M
2024Q2
459
63.44M
108.94%
-9.21M
2024Q1
453
63.54M
109.13%
-8.68M
2023Q4
430
62.90M
109.00%
-9.55M
2023Q3
414
62.85M
109.61%
-11.90M
2023Q2
426
63.03M
109.93%
-13.27M
2023Q1
427
63.10M
110.08%
-9.14M
2022Q4
426
67.66M
118.40%
-4.66M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
RA Capital Management, LP
10.11M
16.66%
+402.32K
+4.14%
Dec 31, 2024
Westfield Capital Management Company, L.P.
5.53M
9.11%
+394.47K
+7.68%
Dec 31, 2024
Avoro Capital Advisors LLC
5.10M
8.41%
+114.17K
+2.29%
Dec 31, 2024
Artisan Partners Limited Partnership
4.45M
7.33%
+39.31K
+0.89%
Dec 31, 2024
Janus Henderson Investors
4.38M
7.22%
+193.69K
+4.63%
Dec 31, 2024
Fidelity Management & Research Company LLC
4.36M
7.18%
-196.51K
-4.32%
Dec 31, 2024
Capital International Investors
2.86M
4.72%
+753.86K
+35.74%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
2.73M
4.49%
+960.50K
+54.42%
Dec 31, 2024
T. Rowe Price Associates, Inc.
2.28M
3.76%
+162.08K
+7.64%
Dec 31, 2024
MFS Investment Management
1.86M
3.07%
-415.00
-0.02%
Dec 31, 2024
查看更多
持股ETF
更新时间: 4月6日 周日
更新时间: 4月6日 周日
机构名称
占比
Harbor Health Care ETF
16.1%
Virtus LifeSci Biotech Products ETF
1.93%
BNY Mellon Innovators ETF
1.85%
Tema Cardiovascular and Metabolic ETF
1.43%
American Century Focused Dynamic Growth ETF
1.43%
ProShares Ultra Nasdaq Biotechnology
0.94%
Invesco Nasdaq Biotechnology ETF
0.9%
JPMorgan Healthcare Leaders ETF
0.66%
iShares Biotechnology ETF
0.61%
Main Thematic Innovation ETF
0.61%
查看更多
Harbor Health Care ETF
占比16.1%
Virtus LifeSci Biotech Products ETF
占比1.93%
BNY Mellon Innovators ETF
占比1.85%
Tema Cardiovascular and Metabolic ETF
占比1.43%
American Century Focused Dynamic Growth ETF
占比1.43%
ProShares Ultra Nasdaq Biotechnology
占比0.94%
Invesco Nasdaq Biotechnology ETF
占比0.9%
JPMorgan Healthcare Leaders ETF
占比0.66%
iShares Biotechnology ETF
占比0.61%
Main Thematic Innovation ETF
占比0.61%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据